Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 394

1.

Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro.

Chen XF, Wang JA, Hou J, Gui C, Tang LJ, Chen XQ, Xie XJ, Jiang JJ, Cai JF, Chen HS, Lu HS, Chen H.

Clin Sci (Lond). 2009 May 1;116(11):819-26. doi: 10.1042/CS20080235.

PMID:
19086920
2.

Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors.

Lesauskaite V, Tanganelli P, Sassi C, Neri E, Diciolla F, Ivanoviene L, Epistolato MC, Lalinga AV, Alessandrini C, Spina D.

Hum Pathol. 2001 Sep;32(9):1003-11.

PMID:
11567232
4.

Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.

Louwrens HD, Kwaan HC, Pearce WH, Yao JS, Verrusio E.

Eur J Vasc Endovasc Surg. 1995 Oct;10(3):289-93.

PMID:
7552526
5.

Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect.

Castoldi G, di Gioia CR, Travaglini C, Busca G, Redaelli S, Bombardi C, Stella A.

Clin Exp Pharmacol Physiol. 2007 Mar;34(3):205-9.

PMID:
17250640
6.

Enhanced embryonic nonmuscle myosin heavy chain isoform and matrix metalloproteinase expression in aortic abdominal aneurysm with rapid progression.

Kamijima T, Isobe M, Suzuki J, Fukui D, Arai M, Urayama H, Nishimaki K, Sekiguchi M, Kawasaki S.

Cardiovasc Pathol. 1999 Sep-Oct;8(5):291-5.

PMID:
10533961
7.

Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms.

Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P.

Circulation. 1999 Jan 5-12;99(1):96-104.

8.

Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.

Schmidt R, Bültmann A, Ungerer M, Joghetaei N, Bülbül O, Thieme S, Chavakis T, Toole BP, Gawaz M, Schömig A, May AE.

Circulation. 2006 Feb 14;113(6):834-41. Epub 2006 Feb 6.

9.

Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease.

Absi TS, Sundt TM 3rd, Tung WS, Moon M, Lee JK, Damiano RR Jr, Thompson RW.

J Thorac Cardiovasc Surg. 2003 Aug;126(2):344-57; discission 357.

10.

Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.

Guo RW, Yang LX, Wang H, Liu B, Wang L.

Regul Pept. 2008 Apr 10;147(1-3):37-44. doi: 10.1016/j.regpep.2007.12.005. Epub 2008 Jan 5.

PMID:
18252266
11.

Downregulation of FHL1 expression in thoracic aortic dissection: implications in aortic wall remodeling and pathogenesis of thoracic aortic dissection.

Weng J, Liao M, Zou S, Bao J, Zhou J, Qu L, Feng R, Feng X, Zhao Z, Jing Z.

Ann Vasc Surg. 2011 Feb;25(2):240-7. doi: 10.1016/j.avsg.2010.10.001. Epub 2010 Dec 3.

PMID:
21126853
12.

Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm.

Moran CS, Cullen B, Campbell JH, Golledge J.

J Vasc Res. 2009;46(3):209-17. doi: 10.1159/000163019. Epub 2008 Oct 16.

PMID:
18931513
13.

Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN.

Lizarbe TR, Tarín C, Gómez M, Lavin B, Aracil E, Orte LM, Zaragoza C.

Am J Pathol. 2009 Oct;175(4):1421-30. doi: 10.2353/ajpath.2009.080845. Epub 2009 Sep 24.

14.

Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm.

Gredmark-Russ S, Dzabic M, Rahbar A, Wanhainen A, Björck M, Larsson E, Michel JB, Söderberg-Nauclér C.

J Mol Med (Berl). 2009 Apr;87(4):347-56. doi: 10.1007/s00109-008-0413-4. Epub 2008 Dec 16.

PMID:
19083194
15.

Expression and localization of vascular endothelial growth factor in normal abdominal aorta and abdominal aortic aneurysm.

Nishibe T, Dardik A, Kondo Y, Kudo F, Muto A, Nishi M, Nishibe M, Shigematsu H.

Int Angiol. 2010 Jun;29(3):260-5.

PMID:
20502414
16.

Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice.

Gitlin JM, Trivedi DB, Langenbach R, Loftin CD.

Cardiovasc Res. 2007 Jan 1;73(1):227-36. Epub 2006 Oct 27.

PMID:
17137566
17.

Expression of matrix Gla protein and osteonectin mRNA by human aortic smooth muscle cells.

Hao H, Hirota S, Ishibashi-Ueda H, Kushiro T, Kanmatsuse K, Yutani C.

Cardiovasc Pathol. 2004 Jul-Aug;13(4):195-202.

PMID:
15210134
18.

Characteristics of TAV- and BAV-associated thoracic aortic aneurysms--smooth muscle cell biology, expression profiling, and histological analyses.

Blunder S, Messner B, Aschacher T, Zeller I, Türkcan A, Wiedemann D, Andreas M, Blüschke G, Laufer G, Schachner T, Bernhard D.

Atherosclerosis. 2012 Feb;220(2):355-61. doi: 10.1016/j.atherosclerosis.2011.11.035. Epub 2011 Nov 28.

PMID:
22178424
19.

EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.

Ju XZ, Yang JM, Zhou XY, Li ZT, Wu XH.

Clin Cancer Res. 2008 Jan 15;14(2):494-501. doi: 10.1158/1078-0432.CCR-07-1072.

20.

EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.

Schmidt R, Redecke V, Breitfeld Y, Wantia N, Miethke T, Massberg S, Fischel S, Neumann FJ, Schömig A, May AE.

Thromb Haemost. 2006 Jan;95(1):151-8.

PMID:
16543974

Supplemental Content

Support Center